Combined analysis of intratumoral human equilibrative nucleoside transporter 1 (hENT1) and ribonucleotide reductase regulatory subunit M1 (RRM1) expression is a powerful predictor of survival in patients with pancreatic carcinoma treated with adjuvant gem
Combined analysis of intratumoral human equilibrative nucleoside transporter 1 (hENT1) and ribonucleotide reductase regulatory subunit M1 (RRM1) expression is a powerful predictor of survival in patients with pancreatic carcinoma treated with adjuvant gem
复制标题
肿瘤内人平衡核苷转运蛋白 1 (hENT1) 和核糖核苷酸还原酶调节亚基 M1 (RRM1) 表达的联合分析是接受 gem 辅助治疗的胰腺癌患者生存的有力预测因子
作者：
Nakagawa N;Murakami Y;Uemura K;Sudo T;Hashimoto Y;Kondo N;Sueda T.
